The effective dose of butorphanol tartrate in patients of different ages undergoing painless gastroscopy

不同年龄段患者接受无痛胃镜检查时,酒石酸布托啡诺的有效剂量

阅读:1

Abstract

OBJECTIVE: This study evaluated the 50% effective dose (ED(50)) and 95% effective dose (ED(95)) of butorphanol tartrate in patients undergoing painless gastroscopy. METHODS: Patients who underwent painless gastroscopy at Binzhou Medical University Hospital were divided into the youth, middle-aged, and older groups. The ED(50) and ED(95) required for successful sedation using butorphanol tartrate were measured using the Dixon up-and-down method in patients in the different age groups. Patients in each group were administered intravenous butorphanol 5 minutes before gastroscopy. Each patient was administered 2 mg/kg propofol. The ED(50) and ED(95) of butorphanol were calculated using probit analysis. RESULTS: In total, 95 patients were included. The ED(50)s of butorphanol in the youth, middle-aged, and older groups were 7.384, 6.657, and 6.364 μg/kg, respectively. The ED(95)s of butorphanol doses in these groups were 9.108, 8.419, and 7.348 μg/kg, respectively. CONCLUSIONS: The ED(50) and ED(95) varied among the age groups, indicating that the effective dose decreases with age.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。